Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: J Affect Disord. 2018 Feb 17;232:219–228. doi: 10.1016/j.jad.2018.02.053

Table 4.

Within and Between-Group Effect Sizes for continuous outcomes

Within-Group Effect Sizes Between-Group Effect Sizes

iDBT-ST Waitlist iDBT-ST vs Waitlist
Outcome TX FU RBL TX T2 T4
SSI 0.81 0.62 0.25 0.32 −0.72 −1.06
AUDIT 0.75 0.37 0.26 0.34 −0.73 −0.22
DERS 0.42 0.15 0.06 0.39 0.34 0.20

Note. All effect sizes are reported Cohen’s D; TX=Treatment phase, FU=Follow-up,

RBL=Repeated Baseline, T2=Month 2 and end of treatment portion for iDBT-ST and beginning for treatment for waitlist, T4=Month 4 and end of follow-up period for iDBT-ST and end of treatment for waitlist.